Novel prism-free SPR technology improves kinetic analysis of aptamer interactions in various biomedical applications, suggesting better drug discovery methods.
Surface plasmon resonance (SPR) is a benchmark for label‐free biomolecular interaction analysis, but traditional prism‐based systems are costly, time‐consuming, and limited in multiplexing. We present a prism‐free, low‐cost, single‐use polymer‐based Au nanograting SPR imaging (SPRi) platform using normal‐incidence optics and camera‐based detection. Integrated with a microarray, the platform demonstrates multiplexed analysis capability. Furthermore, the incorporation of a custom microfluidic design enables simultaneous, multi‐concentration kinetic analysis in a single step. Demonstrated using thrombin–aptamer interactions with 1 s time resolution, the system yielded dissociation constants of 10.1 ± 0.05 n m (kinetic) and 8.71 ± 0.59 n m (steady‐state), consistent with literature values. This approach offers high‐throughput potential for aptamer screening, drug discovery, biomedical applications, and life science research.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: